Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia Interventions: Drug: Teriflunomide; Drug: Dexamethasone Sponsors: Peking University People ' s Hospital; Beijing Luhe Hospital; Chinese PLA General Hospital; Navy General Hospital, Beijing; Beijing Hospital; Beijing Friendship Hospital; Peking University First Hospital; Peking University Third Hospital; China-Japan Friendship Hospital; Beijing Tsinghua Changgeng Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials